Adherence to GLP-1s better than earlier reported Source: Marshall, LZ et al Trends in 1-year persistence and adherence among initiators of high-potency, weight lossindicated glucagon-like peptide 1 receptor agonists, J Man Care Pharm February 27, 2026 Multiple studies have reported low adherence to GLP-1 medications to treat obesity, and some have cited this as a reason why employers should not cover these medications
This phospholipid bilayer (a double layer of fats) mimics the body's natural cellular structure
In major clinical trials, such as the landmark STEP 1 trial published in the New England Journal of Medicine , a once-weekly injection of semaglutide 2.4 mg resulted in an average body weight reduction of roughly 14.9% over 68 weeks
Increase protein intake, stay hydrated, maintain your eating schedule, and avoid trigger foods
Patients at our NYC clinic often ask why peptide therapy feels more expensive than other wellness treatments